U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 211882

Marketing Status: Prescription
Active Ingredient: TAZAROTENE
Proprietary Name: ARAZLO
Dosage Form; Route of Administration: LOTION; TOPICAL
Strength: 0.045%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N211882
Product Number: 001
Approval Date: Dec 18, 2019
Applicant Holder Full Name: BAUSCH HEALTH US LLC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top